Biomarkers for severe COVID-19 by Xin Li, Kelvin K.W. To

Get full text

Socioeconomic disparity trends in diagnostic imaging, treatments, and survival for non‐small cell lung cancer 2007‐2016 by Monica Shah, Ambica Parmar, Kelvin K. W. Chan

Get full text

The robust estimation method for a finite mixture of Poisson mixed-effect models by Xiang, Liming, Yau, Kelvin K. W., Lee, Andy H.

Get full text
Get full text

Value‐based pricing: Toward achieving a balance between individual and population gains in health benefits by Ambica Parmar, Tina Jiao, Ronak Saluja, Kelvin K. W. Chan

Get full text

Transferability of real-world data across borders for regulatory and health technology assessment decision-making by Ashley Jaksa, Patrick J. Arena, Patrick J. Arena, Kelvin K. W. Chan, Kelvin K. W. Chan, Rami H. Ben-Joseph, Páll Jónsson, Ulka B. Campbell

Get full text

Comparing Manufacturer Submitted and Pan-Canadian Oncology Drug Review Reanalysed Incremental Cost-Effectiveness Ratios for Novel Oncology Drugs by Ronak Saluja, Tina Jiao, Liza Koshy, Matthew Cheung, Kelvin K. W. Chan

Get full text

Impact of limited sample size and follow-up on single event survival extrapolation for health technology assessment: a simulation study by Jaclyn M. Beca, Kelvin K. W. Chan, David M. J. Naimark, Petros Pechlivanoglou

Get full text

Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials Group by Louis Everest, Bingshu E. Chen, Annette E. Hay, Matthew C. Cheung, Kelvin K. W. Chan

Get full text

Sex-Based Analysis of Quality Indicators of End-of-Life Care in Gastrointestinal Malignancies by Caitlin S. Lees, Hsien Seow, Kelvin K. W. Chan, Anastasia Gayowsky, Shaila J. Merchant, Aynharan Sinnarajah

Get full text

Clinician Perspectives of COVID-19-Related Cancer Drug Funding Measures in Ontario by Rohini D. Naipaul, Rebecca E. Mercer, Kelvin K. W. Chan, Lyndee Yeung, Leta Forbes, Scott Gavura

Get full text

Comparative Effectiveness and Safety of Trastuzumab Biosimilars to Herceptin for Adjuvant Treatment of HER2+ Breast Cancer by Caroline Muñoz, Xiaochen Tai, Jessica Arias, Andrea Eisen, Munaza Chaudhry, Scott Gavura, Kelvin K. W. Chan

Get full text

The effectiveness of rituximab and HIV on the survival of Ontario patients with diffuse large B‐cell lymphoma by Steven Habbous, Helen Guo, Jaclyn Beca, Wei Fang Dai, Wanrudee Isaranuwatchai, Matthew Cheung, Kelvin K. W. Chan

Get full text

Poor recognition of risk factors for hepatitis B by physicians prescribing immunosuppressive therapy: a call for universal rather than risk-based screening. by Alissa Visram, Kelvin K W Chan, Phyllis McGee, Jordana Boro, Lisa K Hicks, Jordan J Feld

Get full text

Systemic therapy in the curative treatment of head and neck squamous cell cancer: a systematic review by Eric Winquist, Chika Agbassi, Brandon M. Meyers, John Yoo, Kelvin K. W. Chan, the Head and Neck Disease Site Group

Get full text

Co-stimulation With TLR7 Agonist Imiquimod and Inactivated Influenza Virus Particles Promotes Mouse B Cell Activation, Differentiation, and Accelerated Antigen Specific Antibody Pr... by Can Li, Can Li, Can Li, Can Li, Kelvin K. W. To, Kelvin K. W. To, Kelvin K. W. To, Kelvin K. W. To, Anna J. X. Zhang, Anna J. X. Zhang, Anna J. X. Zhang, Anna J. X. Zhang, Andrew C. Y. Lee, Andrew C. Y. Lee, Andrew C. Y. Lee, Andrew C. Y. Lee, Houshun Zhu, Winger W. N. Mak, Winger W. N. Mak, Winger W. N. Mak, Winger W. N. Mak, Ivan F. N. Hung, Kwok-Yung Yuen, Kwok-Yung Yuen, Kwok-Yung Yuen, Kwok-Yung Yuen

Get full text

Corrigendum: Co-stimulation with TLR7 agonist imiquimod and inactivated Influenza virus particles promotes mouse B cell activation, differentiation, and accelerated antigen specifi... by Can Li, Can Li, Can Li, Can Li, Kelvin K.W. To, Kelvin K.W. To, Kelvin K.W. To, Kelvin K.W. To, Anna J. X. Zhang, Anna J. X. Zhang, Anna J. X. Zhang, Anna J. X. Zhang, Andrew C.Y. Lee, Andrew C.Y. Lee, Andrew C.Y. Lee, Andrew C.Y. Lee, Houshun Zhu, Winger W.N. Mak, Winger W.N. Mak, Winger W.N. Mak, Winger W.N. Mak, Ivan F. N. Hung, Kwok-Yung Yuen, Kwok-Yung Yuen, Kwok-Yung Yuen, Kwok-Yung Yuen

Get full text

Nivolumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective Tertiary Centre’s Real-World Experience by Yue (Jennifer) Du, Rui Fu, Justin T. Levinsky, Pabiththa Kamalraj, Kelvin K. W. Chan, Ambica Parmar, Antoine Eskander, Martin Smoragiewicz

Get full text

Primary care utilization for patients with newly diagnosed cancer during the COVID-19 pandemic: a population-based study by Ying Ling, Matthew C. Cheung, Kelvin K.W. Chan, Aisha Lofters, Colleen Fox, Aditi Patrikar, Ning Liu, Simron Singh

Get full text

A Systematic Review and Network Meta-Analysis of Biologic Agents in the First Line Setting for Advanced Colorectal Cancer. by Alexander Kumachev, Marie Yan, Scott Berry, Yoo-Joung Ko, Maria C R Martinez, Keya Shah, Kelvin K W Chan

Get full text

A Real-World Comparison Between Adjuvant Docetaxel with Cyclophosphamide (TC) and Anthracycline–Taxane Chemotherapy in Early HER-2 Negative Breast Cancer by Danilo Giffoni de Mello Morais Mata, Rossanna C. Pezo, Kelvin K. W. Chan, Ines Menjak, Andrea Eisen, Maureen Trudeau

Get full text